No Data
No Data
Trump Government Likely to Still Pass Biosecure Act -- Market Talk
Hong Kong stocks are active | CRO concepts generally rise, medical insurance negotiations support innovative drugs, and under the environment of interest rate cuts, global biomedical financing will rebound.
The concept of CRO is generally on the rise. As of the time of publication, Asymchem Laboratories (06821) rose by 4.95%, to HKD 59.4; Tigermed (03347) rose by 4.94%, to HKD 38.25; Wuxi Apptec (02359) rose by 3.88%, to HKD 53.5.
Wuxi bio launches the technology platform WuXia RidGS, empowering customers to develop non-antibiotic cell lines.
Shanghai, October 28, 2024 / PRNewswire / -- China's leading contract research, development, and manufacturing organization (CRDMO) Wuxi Biologics (2269.HK) announces the launch of the WuXia RidGS cell line construction platform based on high-yield glutamine synthetase (GS) in Chinese hamster ovary (CHO) expression system. The platform serves as a non-antibiotic cell line development tool, utilizing zinc finger nuclease (ZFN) technology to knock out the endogenous GS gene in CHO cells. WuXia RidGS is derived from
HK Stocks Update: Pharmaceutical stocks continue to strengthen, AstraZeneca-B (01541) expands its gains in the afternoon. Hong Kong approval mechanism will be extended to all new drugs starting from November.
Pharmaceutical stocks continue to strengthen, as of the time of publication, Yimengangke-B (01541) rose by 22.76% to 7.65 Hong Kong dollars; zai lab (09688) rose by 15.25% to 25.7 Hong Kong dollars; Heyu-B (02256) rose by 8.82% to 4.32 Hong Kong dollars; tigermed (03347) rose by 11.65% to 41.2 Hong Kong dollars; wuxi bio (02269) rose by 6.68% to 17.56 Hong Kong dollars.
Trending Industry Today: TIGERMED Leads Gains In CRO Stocks
Wuxi Bio [02269] is now trading at 17.3 Hong Kong dollars, with a rise of 5.10%.
As of 10:50, Wuxi Bio [02269] reported a share price of 17.3 Hong Kong dollars, up 0.84 Hong Kong dollars or 5.10% from the previous closing price of 16.46 Hong Kong dollars, with a turnover of 458.7831 million Hong Kong dollars. The highest price today is 17.3 Hong Kong dollars, and the lowest price is 16.42 Hong Kong dollars. Based on the closing price from yesterday, the 10-day average price is 16.49 Hong Kong dollars, the 50-day average price is 13.77 Hong Kong dollars, and the current PE ratio is 18.29 times. The 14-day relative strength index is reported as 42.09.